Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19

NCT04388579 | Completed

• 1 other identifier: 046i/17
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 3

Brief Summary

This study applied the Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) on respiratory patients who had their on-going ambulatory Pulmonary Rehabilitation program interrupted due to the COVID-19 outbreak. The research hypothesis is that ranking patients' self-efficacy is a useful screening tool to support patients' follow-up on a Pulmonary Rehabilitation telehealth solution to be explored during the COVID-19 outbreak.

Conditions

Respiratory Disease

Keywords

self-efficacy; PRAISE; Pulmonary Telerehabilitation

Outcome Measures

Primary Outcomes (1)

• Patient's self-efficacy

  Vincent and co-authors (2011) proposed the Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE). The PRAISE tool is composed by a total of 15 items, combining 10 items from the General Self-Efficacy Scale (GSE) by Schwarzer and Jerusalem (1995), and 5 new specific items related to Pulmonary Rehabilitation. Each item is scored from 1 to 4 with a total range from 15 to 60, with higher scores indicating higher levels of self-efficacy. This study applies the Portuguese PRAISE version by Santos CD and co-authors (2019).

  3 days

Secondary Outcomes (2)

• Respiratory exercises

  3 days

• Physical activity

  3 days

Other Outcomes (2)

• Treatment sessions completed

  3 days

• Treatment weekly frequency

  3 days

Interventions

Pulmonary Rehabilitation OTHER

Respiratory Physiotherapy, Exercise Therapy, Patient Education

Eligibility Criteria

• Age: 18 Years - 88 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

100 adults attending an outpatient Pulmonary Rehabilitation program based at Hospital Pulido Valente from Centro Hospitalar Universitário Lisboa Norte, in Lisbon, Portugal

You may qualify if:

• Patients with acute respiratory disease
• Patients with chronic respiratory disease
• Patients attending a hospital-based Pulmonary Rehabilitation program

You may not qualify if:

• Cognitive deficit for answering a questionnaire

Sponsors & Collaborators

• University of Lisbon: lead
• Centro Hospitalar Lisboa Norte: collaborator
• Fundação para a Ciência e a Tecnologia: collaborator
• Nippon Gases Portugal, Unipessoal, Lda.: collaborator

Study Sites (3)

Nippon Gases Portugal Unipessoal Lda

Maia, Porto District, 4470- 177, Portugal

Location

Universidade de Lisboa, Faculdade de Medicina, Instituto de Saúde Ambiental (ISAMB)

Lisbon, 1649-028, Portugal

Location

Centro Hospitalar Universitário Lisboa Norte, Hospital Pulido Valente, Unidade de Reabilitação Respiratória

Lisbon, 1649-035, Portugal

Location

MeSH Terms

Conditions

Respiration Disorders

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

• Catarina D Santos, MSc

  University of Lisbon

  PRINCIPAL INVESTIGATOR

• Cristina Bárbara, PhD

  University of Lisbon

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD student, Physiotherapist MSc

Study Record Dates

• First Submitted: May 12, 2020
• First Posted: May 14, 2020
• Study Start: March 20, 2020
• Primary Completion: March 27, 2020
• Study Completion: March 27, 2020
• Last Updated: May 14, 2020

Record last verified: 2020-05

Data Sharing

• IPD Sharing: Will not share

Locations

PT (3)